Making sense of the Food and Drug Administration

Seminars in Pediatric Surgery

Volumn 15, Issue 4, 2006, Pages 293-301

  Connor, Jessica Anne ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Center for Device and Radiological Health (CDRH); Food and Drug Administration (FDA); Humanitarian use device (HUD); Humanitarian use device exemption (HDE); Investigation device exemption (IDE); Pre market approval (PMA); Pre market notification (510(k))

Indexed keywords

ARTICLE; CHILD WELFARE; CLASSIFICATION; DEVICE; EMERGENCY CARE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEART ASSIST DEVICE; HUMAN; IMPLANT; MANAGEMENT; MARKETING; MEDICAL INSTRUMENTATION; PATIENT RIGHT; PATIENT SAFETY; PHYSICIAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROSTHESIS; STENT; SURGICAL INSTRUMENT; URINE CATHETER;

ALTRUISM; CHILD; DEVICE APPROVAL; EQUIPMENT DESIGN; EQUIPMENT SAFETY; HUMANS; SURGICAL EQUIPMENT; SURGICAL INSTRUMENTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33750032246     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2006.07.009     Document Type: Article

References (24)

1. Spurgin E.A. Planning effective interaction with FDA. Diabetes Technol Ther 6 6 (2004) 770-775
2. Kaplan A.V., Baim D.S., Smith J.J., et al. Medical device development: from prototype to regulatory approval. Circulation 109 (2004) 3068-3072
3. Maisel W.H. Medical device regulation: an introduction for the practicing physician. Ann Intern Med 140 4 (2004) 296-302
4. Guidance for industry and FDA staff: premarket assessment of pediatric medical devices (2004), U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD. http://www.fda.gov/cdrh/mdufma/guidance/1220.html Available from: http://www.fda.gov/cdrh/mdufma/guidance/1220.html. Accessed April 30, 2006.
5. An overview of FDA: protecting consumers, protecting public health (2002), U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD. http://www.fda.gov/oc/opacom/fda101/sld001.html Available from: http://www.fda.gov/oc/opacom/fda101/sld001.html. Accessed April 30, 2006.
6. Saviola J. The FDA's role in medical device clinical studies of human subjects. J Neural Eng 2 (2005) S1-S4
7. Rados C. Medical device and radiological health regulations come of age. FDA Consumer (2006) 59-65 January/February
8. 21 U.S.C. §321.
9. Kessler L., and Richter K. Technology assessment of medical devices at the center for devices and radiological health. Am J Manag Care 4 (1998) SP129-SP135
10. Hackett J.L., and Gutman S.I. Introduction to the Food and Drug Administration (FDA) regulatory process. J Proteome Res 4 4 (2005) 1110-1113
11. Device classes (2002), U.S. Department of Health and Human Services Food and Drug Administration, Rockville, MD. http://www.fda.gov/cdrh/devadvice/3132.html#class_1 Available from: http://www.fda.gov/cdrh/devadvice/3132.html#class_1. Accessed April 30, 2006.
12. 21 U.S.C. §360(c).
13. General controls for medical devices (2002), U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD. http://www.fda.gov/cdrh/devadvice/363.html Available from: http://www.fda.gov/cdrh/devadvice/363.html. Accessed April 30, 2006.
14. Munzer R. U.S. medical device classification. IEEE Eng Med Biol Mag (2004) 207-298
15. Kaplan A.V., Harvey E.D., Kuntz R.E., et al. Humanitarian use devices/humanitarian use device exemptions in cardiovascular medicine. Circulation 112 (2005) 2883-2886
16. Rinaldi J.E., Chen E.A., and Berman M. Pediatric circulatory support: an FDA perspective. ASAIO J 51 (2005) 533-535
17. Listing of CDRH humanitarian device exemption summaries of safety and possible benefit (1995), U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfHDE/HDEInformation.cfm Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfHDE/HDEInformation.cfm. Accessed April 30, 2006.
18. McKneally M.F., and Daar A.S. Introducing new technologies: protecting subjects of surgical innovation and research. World J Surg 27 (2003) 903-935
19. Caldwell P.H.Y., Murphy S.B., and Butow P.N. Clinical trials in children. Lancet 364 (2004) 803-811
20. Steinbrook R. Testing medications in children. N Engl J Med 347 18 (2002) 1462-1470
21. 21 CFR Part 812.
22. Significant risk and nonsignificant risk medical device studies (1995), U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD. http://www.fda.gov/cdrh/d861.html Available from: http://www.fda.gov/cdrh/d861.html. Accessed April 30, 2006.
23. 21 CFR 812.3(i).
24. Determination of intended use for 510(k) Devices: guidance for CDRH staff (update to K98-1) (2002), U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD. http://www.fda.gov/cdrh/ode/guidance/857.pdf Available from: http://www.fda.gov/cdrh/ode/guidance/857.pdf. Accessed April 30, 2006.